基本説明
Provides an account of joint policy development by EC/EU member states to counter drug trafficking since the late 1960s.
Full Description
Martin Elvins' book is the first to trace the evolution of anti-drugs policies at European Union level from the late 1960s to the present. Phases of drug policy development, key policy actors and institutions are described with particular reference to the influence of transnational networks of expertise. Policy development is placed in the context of both European integration and a broad harmonization of international policies against drug trafficking. Concerns are also raised about secretive and anti-democratic features on intergovernmental EU decision-making.
Contents
List of Tables and Figures List of Acronyms and Abbreviations Map of the Member States of the European Union Introduction PART I: STATE SOVEREIGNTY, DRUGS AND GLOBAL CHANGE Transnational Threat in the 'Globalized' Era The Evolution of International Drug Control Policy Networks, Expertise and International Governance Epistemic Communities PART II: THE CONVERGENCE OF EUROPEAN DRUG ENFORCEMENT POLICIES Europe and Drugs: an Introduction MAG, Trevi, CELAD and the pre-Union blueprint for Policy-Making on Drugs European Drug Policy and Maastricht: New Momentum, Familiar Policies Expert Influence and EU Drugs Policy, 1993-1999 EU Drug Policy-Making Under the Amsterdam Treaty Case Studies PART III: CONCLUSIONS Experts, Technocracy, and European Drug Enforcement Policies Drugs, the State, and the Political System of the European Union Appendix: List of Participants in the EU Drug Expertise Missions Notes Bibliography Glossary of EU and EU-related Terms Index
